Abstract
Penicillin class antibiotics have demonstrated varying degrees of in vivo and in vitro success when tested against Chlamydia trachomatis. The activity of ampicillin-sulbactam, an agent commonly utilized in the treatment of pelvic infections, was tested to ascertain if any antichlamydial activity is present. Up to six endocervical isolates of C. trachomatis were tested against each of five antibiotics including doxycycline, erythromycin, clindamycin, ampicillin/sulbactam, and sulbactam alone. McCoy cell monolayers were inoculated with high inclusion counts of 10,000–30,000 inclusion-forming units (IFU) per coverslip, and exposed to each antibiotic. Up to nine subsequent antibiotic free culture passes were performed to assess the viability of abnormal inclusions. Doxycycline, erythromycin, and clindamycin achieved 100% eradication of inclusions at concentrations of 4.0, 2.0, and 1.0 µg/mL. Exposure to ampicillin/sulbactam resulted in a greater than 99% reduction in the inclusion count at 32.0 µg/mL, while sulbactam by itself demonstrated considerably less activity. Abnormal inclusions were noted only in the ampicillin/sulbactam exposed cells, and these, plus all inclusions remaining following sublethal exposure to the other antibiotics, resulted in regrowth to control levels in subsequent passes. Doxycycline and erythromycin demonstrated excellent activity. Clindamycin and ampicillin/sulbactam also significantly reduced inclusion formation, and therefore may provide adequate C. trachomatis coverage in patients receiving these antibiotics for pelvic infections.
Full Text
The Full Text of this article is available as a PDF (476.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bailey J. M., Heppleston C., Richmond S. J. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence. Antimicrob Agents Chemother. 1984 Jul;26(1):13–16. doi: 10.1128/aac.26.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowie W. R., Alexander E. R., Holmes K. K. Eradication of Chlamydia trachomatis from the urethras of men with nongonococcal urethritis by treatment with amoxicillin. Sex Transm Dis. 1981 Apr-Jun;8(2):79–81. doi: 10.1097/00007435-198104000-00010. [DOI] [PubMed] [Google Scholar]
- Bowie W. R. In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis. Antimicrob Agents Chemother. 1986 Apr;29(4):713–715. doi: 10.1128/aac.29.4.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowie W. R. Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis. Antimicrob Agents Chemother. 1982 Feb;21(2):339–340. doi: 10.1128/aac.21.2.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowie W. R., Manzon L. M., Borrie-Hume C. J., Fawcett A., Jones H. D. Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women. Am J Obstet Gynecol. 1982 Jan 15;142(2):125–129. doi: 10.1016/s0002-9378(16)32325-0. [DOI] [PubMed] [Google Scholar]
- Hammerschlag M. R., Gleyzer A. In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis. Antimicrob Agents Chemother. 1983 Mar;23(3):493–494. doi: 10.1128/aac.23.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuo C. C., Wang S. P., Grayston J. T. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother. 1977 Jul;12(1):80–83. doi: 10.1128/aac.12.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee C. K., Bowie W. R., Alexander E. R. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation. Antimicrob Agents Chemother. 1978 Mar;13(3):441–445. doi: 10.1128/aac.13.3.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin D. H., Pastorek J. G., 2nd, Faro S. In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis. Sex Transm Dis. 1986 Apr-Jun;13(2):81–87. doi: 10.1097/00007435-198604000-00006. [DOI] [PubMed] [Google Scholar]
- Mourad A., Sweet R. L., Sugg N., Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother. 1980 Nov;18(5):696–698. doi: 10.1128/aac.18.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noguera X., Ferrer M., Ortolá E., López-Marín L. Evaluation of doxycycline in the treatment of urethritis and cervicitis caused by Chlamydia trachomatis. Clin Ther. 1986;9 (Suppl A):33–37. [PubMed] [Google Scholar]
- Ridgway G. L., Owen J. M., Oriel J. D. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. Br J Vener Dis. 1978 Apr;54(2):103–106. doi: 10.1136/sti.54.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schachter J., Grossman M. Chlamydial infections. Annu Rev Med. 1981;32:45–61. doi: 10.1146/annurev.me.32.020181.000401. [DOI] [PubMed] [Google Scholar]
- Segreti J., Kessler H. A., Kapell K. S., Trenholme G. M. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. Antimicrob Agents Chemother. 1987 Jan;31(1):100–101. doi: 10.1128/aac.31.1.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walsh M., Kappus E. W., Quinn T. C. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother. 1987 May;31(5):811–812. doi: 10.1128/aac.31.5.811. [DOI] [PMC free article] [PubMed] [Google Scholar]